Celecoxib
Celecoxib is a well-established selective COX-2 inhibitor (coxib) designed to manage severe musculoskeletal and joint diseases. By binding selectively to the active site of the COX-2 enzyme, it disrupts the biochemical production of inflammatory mediators without affecting homeostatic tissue mechanisms. This process effectively alleviates persistent joint tenderness, reduces swelling, increases range of motion, and maintains low gastrointestinal toxicity risk during extended treatment periods.
Stomach-friendly
Joint-saver
Cancer-preventer
Stomach-friendly
Joint-saver
Cancer-preventer
High Purity & Efficacy
USP / BP / EP / IP Grade Compliance
Stringent Quality Control & Batch Consistency
Pharmaceutical Formulations
Oral Solid Dosage (Tablets & Capsules)
Sterile Formulations / Injectables (where applicable)
Custom API Compounding